The goal of the present work was to validate the expression of VEGFR-2 in glioblastoma cells and tissues with respect to the PTEN status and to characterize VEGFR-2-specific functions in glioma cells focusing on clinically relevant therapeutic modalities. Here, PTEN is linked to glioblastoma.